{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Intraosseous Regional Administration of Vancomycin in Total Knee Arthroplasty"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "In a randomised controlled trial, 30 patients scheduled for primary TKA were randomised"
      },
      "Participants": {
        "score": 1,
        "evidence": "30 patients scheduled for primary TKA"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to receive either 250 mg or 500 mg vancomycin via IORA or 1 g via systemic administration"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates whether low-dose intraosseous regional administration (IORA) of vancomycin can achieve tissue concentrations comparable to or exceeding those of systemic administration in total knee arthroplasty (TKA)"
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was the tissue concentration of vancomycin, assessed during the procedure"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was conducted using a computer-generated sequence, with allocation concealment ensured through sealed envelopes"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "30 patients scheduled for primary TKA"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The mean vancomycin concentration in subcutaneous fat was 14 \u03bcg/g in the 250-mg IORA group, 44 \u03bcg/g in the 500-mg IORA group, and 3.2 \u03bcg/g in the systemic group"
      },
      "Harms": {
        "score": 1,
        "evidence": "One patient in the systemic group experienced red man syndrome. No other adverse events were reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of funding]"
      }
    },
    "total_score": 14,
    "max_score": 25
  },
  "model": "gpt-4o"
}